Journal of Thrombosis and Haemostasis, 1538-7933

Journal

More filtering options
  1. 2015
  2. Prophylaxis Escalation in Severe von Willebrand Disease: A Prospective Study from the von Willebrand Disease Prophylaxis Network.

    Abshire, T., Cox-Gill, J., Kempton, C. L., Leebeek, F. W. G., Carcao, M., Kouides, P., Donfield, S. & Erik Berntorp, 2015, In : Journal of Thrombosis and Haemostasis. 13, 9, p. 1585-1589

    Research output: Contribution to journalArticle

  3. 2016
  4. Measuring factor IX activity of nonacog beta pegol with commercially available one-stage clotting and chromogenic assay kits: A two-center study

    Bowyer, A. E., A. Hillarp, Ezban, M., Persson, P. & Kitchen, S., 2016, In : Journal of Thrombosis and Haemostasis. 14, 7, p. 1428-1435

    Research output: Contribution to journalArticle

  5. Population Pharmacokinetics of Plasma-Derived Factor IX: Procedures for Dose Individualization.

    Brekkan, A., Erik Berntorp, Jensen, K., Nielsen, E. I. & Jönsson, S., 2016, In : Journal of Thrombosis and Haemostasis. 14, 4, p. 724-732

    Research output: Contribution to journalArticle

  6. Prospective study of thromboembolism in 1038 children with acute lymphoblastic leukemia - a Nordic Society of Pediatric Hematology and Oncology (NOPHO) study.

    Tuckuviene, R., Ranta, S., Albertsen, B. K., Andersson, N. G., Bendtsen, M. D., Frisk, T., Gunnes, M. W., Helgestad, J., Heyman, M. M., Jonsson, O. G., Mäkipernaa, A., Pruunsild, K., Ulf Tedgård, Trakymiene, S. S. & Ruud, E., 2016, In : Journal of Thrombosis and Haemostasis. 14, 3, p. 485-494

    Research output: Contribution to journalArticle

  7. The lectin complement pathway serine proteases (MASPs) represent a possible crossroad between the coagulation and complement systems in thromboinflammation.

    Kozarcanin, H., Lood, C., Munthe-Fog, L., Sandholm, K., Hamad, O. A., Anders Bengtsson, Skjoedt, M-O., Huber-Lang, M., Garred, P., Ekdahl, K. N. & Nilsson, B., 2016, In : Journal of Thrombosis and Haemostasis. 14, 3, p. 531-545

    Research output: Contribution to journalArticle

  8. 2017
  9. Intensity of factor VIII treatment and the development of inhibitors in non-severe hemophilia A patients: Results of the INSIGHT case-control study

    van Velzen, A. S., Eckhardt, C. L., Peters, M., Leebeek, F. W. G., Escuriola-Ettingshausen, C., Hermans, C., Keenan, R. D., J. Astermark, Male, C., Peerlinck, K., le Cessie, S., Van der Bom, J. G. & Fijnvandraat, K., 2017 Jul 3, In : Journal of Thrombosis and Haemostasis. 15, 7, p. 1422-1429

    Research output: Contribution to journalArticle

  10. Effect of late prophylaxis in hemophilia on joint status: A randomized trial

    Manco-Johnson, M. J., B. Lundin, Funk, S., Peterfy, C., Raunig, D., Werk, M., Kempton, C. L., Reding, M. T., Goranov, S., Gercheva, L., Rusen, L., Uscatescu, M. V., Pierdominici, M., Engelen, S., Pocoski, J., Walker, D. & Hong, W., 2017 Nov, In : Journal of Thrombosis and Haemostasis. 15, 11, p. 2115-2124

    Research output: Contribution to journalArticle

  11. 2018
  12. Genome-wide analysis of genetic determinants of circulating factor VII-activating protease (FSAP) activity

    Olsson, M., Stanne, T. M., Pedersen, A., Lorentzen, E., Kara, E., Martinez-Palacian, A., Rønnow Sand, N. P., Jacobsen, A. F., Sandset, P. M., Sidelmann, J. J., G. Engström, O. Melander, Kanse, S. M. & Jern, C., 2018, In : Journal of Thrombosis and Haemostasis. 16, 10, p. 2024-2034

    Research output: Contribution to journalArticle

  13. 2019
Previous 1 2 Next